Konstantin Matentzoglu
Direktor/Vorstandsmitglied bei Polpharma Biologics Group BV
Profil
Konstantin Matentzoglu is a Member-Supervisory Board at Polpharma Biologics Group BV.
He previously worked as the Chief Executive Officer at Celonic AG and as the SEVP-Business Development & Operations at AYOXXA Biosystems GmbH.
He holds a doctorate degree from Universität Konstanz.
Aktive Positionen von Konstantin Matentzoglu
| Unternehmen | Position | Beginn |
|---|---|---|
| Polpharma Biologics Group BV | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Konstantin Matentzoglu
| Unternehmen | Position | Ende |
|---|---|---|
Celonic AG
 Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Vorstandsvorsitzender | - |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Geschäftsführer | - |
Ausbildung von Konstantin Matentzoglu
| Universität Konstanz | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Celonic AG
Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Health Technology |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Health Technology |
| Polpharma Biologics Group BV |
